MedTrace Logo

The Effect of Combination Ultra Q10 and L-carnitine on the Course of Myelodysplastic Syndrome

NCT02042482 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2014-01-22

No results posted yet for this study

Summary

The purpose of this study is determine whether combination Q10 , L-carnitine and multivitamin and mineral complex is effective in treatment of patients with low and intermidiate1-2 risk Myelodysplastic syndrome

Conditions

Interventions

DIETARY_SUPPLEMENT

Coenzyme Q10U, L-carnitine

Sponsors & Collaborators

  • Weizmann Institute of Science

    collaborator OTHER

  • Kaplan Medical Center

    lead OTHER

Principal Investigators

  • Kalman Kalman, MD · Kaplan Medical Center, Institute of hematology

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2016-05-31
Completion
2016-05-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02042482 on ClinicalTrials.gov